Skip to main content
SpringerLink
Log in

Preventing Diabetes

  • Chapter
  • First Online:
Diabetes Management in Clinical Practice

  • 2282 Accesses

Abstract

The prevalence of diabetes is increasing globally. While environmental factors including obesity and sedentary lifestyle are clearly responsible for this epidemic, the reasons for rise in incidence of Type 1 diabetes (T1D) are less clear. Once considered a disease of affluent countries, diabetes is now disproportionally affecting low and middle-income countries. The last couple of decades have seen significant progress in our understanding of the pathogenesis of these conditions. Randomised trials have demonstrated that Type 2 diabetes (T2D) can be delayed if not prevented. Prevention of T1D, however, has proven more elusive. LADA and gestational diabetes are also under intense scientific scrutiny.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Key References

  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.

    Article  CAS  PubMed  Google Scholar 

  • Alberti KG, Zimmet P, Shaw J. International diabetes federation: a consensus on Type 2 diabetes prevention. Diabet Med. 2007;24(5):451–63.

    Article  CAS  PubMed  Google Scholar 

  • American Diabetes Association. Position statement. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013a;36 Suppl 1:S67–74.

    Article  Google Scholar 

  • American Diabetes Association. Standards of medical care in diabetes–2013. Diabetes Care. 2013b;36 Suppl 1:S11–66.

    Article  Google Scholar 

  • Berends LM, Ozanne SE. Early determinants of type-2 diabetes. Best Pract Res Clin Endocrinol Metab. 2012;26(5):569–80.

    Article  CAS  PubMed  Google Scholar 

  • Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, Tuomi T, et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes. 2008;57(5):1433–7.

    Article  CAS  PubMed  Google Scholar 

  • Daneman D. Type 1 diabetes. Lancet. 2006;367(9513):847–58.

    Article  CAS  PubMed  Google Scholar 

  • Fall CH. Non-industrialised countries and affluence. Br Med Bull. 2001;60:33–50.

    Article  CAS  PubMed  Google Scholar 

  • Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia. 2005;48(11):2206–12.

    Article  CAS  PubMed  Google Scholar 

  • Galtier F. Definition, epidemiology, risk factors. Diabetes Metab. 2010;36(6 Pt 2):628–51.

    Article  CAS  PubMed  Google Scholar 

  • Groop L, Pociot F. Genetics of diabetes – are we missing the genes or the disease? Mol Cell Endocrinol. 2014;382:726–39.

    Google Scholar 

  • Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5–20.

    Article  CAS  PubMed  Google Scholar 

  • Hirschhorn JN. Genetic epidemiology of type 1 diabetes. Pediatr Diabetes. 2003;4(2):87–100.

    Article  PubMed  Google Scholar 

  • International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels: International Diabetes Federation; 2012. Available from: http://www.idf.org/diabetesatlas.

  • Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.

    Article  CAS  PubMed  Google Scholar 

  • Merger SR, Leslie RD, Boehm BO. The broad clinical phenotype of type 1 diabetes at presentation. Diabet Med. 2013;30(2):170–8.

    Article  CAS  PubMed  Google Scholar 

  • Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India:a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol Available online 11 Sept 2013, ISSN 2213-8587. http://dx.doi.org/10.1016/S2213-8587(13)70067-6. http://www.sciencedirect.com/science/article/pii/S2213858713700676.

  • Skyler JS. Primary and secondary prevention of Type 1 diabetes. Diabet Med. 2013;30(2):161–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Skyler JS, Ricordi C. Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man. Diabetes. 2011;60(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  • Staeva TP, Chatenoud L, Insel R, Atkinson MA. Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials. Diabetes. 2013;62(1):9–17.

    Article  CAS  PubMed  Google Scholar 

  • Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem. 2011;57(2):176–85.

    Article  CAS  PubMed  Google Scholar 

  • Thrower SL, Bingley PJ. Prevention of type 1 diabetes. Br Med Bull. 2011;99:73–88.

    Article  CAS  PubMed  Google Scholar 

  • Travers ME, McCarthy MI. Type 2 diabetes and obesity: genomics and the clinic. Hum Genet. 2011;130(1):41–58.

    Article  CAS  PubMed  Google Scholar 

  • Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.

    Article  CAS  PubMed  Google Scholar 

  • Veeraswamy S, Vijayam B, Gupta VK, Kapur A. Gestational diabetes: the public health relevance and approach. Diabetes Res Clin Pract. 2012;97(3):350–8.

    Article  PubMed  Google Scholar 

  • Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem. 2011;57(2):168–75.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Diabetes, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Blizard Institute, London, UK

    Girish Rayanagoudar MBBS, MRCP(UK) & Graham A. Hitman MBBS, MD, FRCP

Authors
  1. Girish Rayanagoudar MBBS, MRCP(UK)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Graham A. Hitman MBBS, MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Graham A. Hitman MBBS, MD, FRCP .

Editor information

Editors and Affiliations

  1. The Royal London Hospital, London, United Kingdom

    Tahseen A. Chowdhury

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Rayanagoudar, G., Hitman, G.A. (2014). Preventing Diabetes. In: Chowdhury, T. (eds) Diabetes Management in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-4471-4869-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4869-2_1

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4868-5

  • Online ISBN: 978-1-4471-4869-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation